thiazoles has been researched along with (r)-n-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shahib, B; Diness, JG; Grunnet, M; Hansen, RS; Jespersen, T; Nissen, JD; Sørensen, US | 1 |
| Bentzen, BH; Christ, T; Diness, JG; Grunnet, M; Jespersen, T; Kappert, U; Matschke, K; Poulet, C; Ravens, U; Skibsbye, L; Wettwer, E; Yuan, L | 1 |
2 other study(ies) available for thiazoles and (r)-n-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine
| Article | Year |
|---|---|
Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.
Topics: 1-Naphthylamine; Acetylcholine; Action Potentials; Alkanes; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Electrocardiography; Female; Guinea Pigs; In Vitro Techniques; Male; Myocardium; Perfusion; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Pyridines; Quinolinium Compounds; Rabbits; Rats; Rats, Sprague-Dawley; Thiazoles; Time Factors | 2010 |
Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria.
Topics: 1-Naphthylamine; Action Potentials; Atrial Fibrillation; Heart Atria; Heart Ventricles; Humans; Membrane Potentials; Myocardium; Myocytes, Cardiac; Pyridines; RNA, Messenger; Small-Conductance Calcium-Activated Potassium Channels; Thiazoles | 2014 |